Bibliography and References:

1. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune
cell responses. Blood, 105(4), 1815-1822.
2. Augello, A., Tasso, R., Negrini, S. M., Cancedda, R., & Pennesi, G. (2007). Cell therapy using
allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced
arthritis. Arthritis Rheum, 56(4), 1175-1186.
3. Ben-Ami, E., Berrih-Aknin, S., & Miller, A. (2011). Mesenchymal stem cells as an immunomodulatory
therapeutic strategy for autoimmune diseases. Autoimmun Rev, 10(7), 410-415.
4. Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., et al.
(2005). Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A,
102(9), 3324-3329.
5. Bonab, M. M., Alimoghaddam, K., Talebian, F., Ghaffari, S. H., Ghavamzadeh, A., & Nikbin, B.
(2006). Aging of mesenchymal stem cell in vitro. BMC Cell Biol, 7, 14.
6. Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., et al.
(2003). Osteoblastic cells regulate the haematopoietic stem cell niche. Nature, 425(6960), 841-846.
7. Carrion, F., Nova, E., Ruiz, C., Diaz, F., Inostroza, C., Rojo, D., et al. (2010). Autologous
mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two
systemic lupus erythematosus patients. Lupus, 19(3), 317-322.
8. Chen, C., Liu, Y., & Zheng, P. (2010). Mammalian target of rapamycin activation underlies HSC
defects in autoimmune disease and inflammation in mice. J Clin Invest, 120(11), 4091-4101.
9. Cheng, Z., Ou, L., Zhou, X., Li, F., Jia, X., Zhang, Y., et al. (2008). Targeted migration of
mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac
performance. Mol Ther, 16(3), 571-579.
10. Choi, E. W., Shin, I. S., Park, S. Y., Park, J. H., Kim, J. S., Yoon, E. J., et al. (2011).
Reversal of serological, immunological and histological dysfunction in systemic lupus erythematosus
mice by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis
Rheum.
11. De Boer, J., Wang, H. J., & Van Blitterswijk, C. (2004). Effects of Wnt signaling on proliferation
and differentiation of human mesenchymal stem cells. Tissue Eng, 10(3-4), 393-401.
12. Deng, W., Han, Q., Liao, L., You, S., Deng, H., & Zhao, R. C. (2005). Effects of allogeneic bone
marrow- derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol,
24(7), 458-463.
13. Derfoul, A., Carlberg, A. L., Tuan, R. S., & Hall, D. J. (2004). Differential regulation of osteogenic
marker gene expression by Wnt-3a in embryonic mesenchymal multipotential progenitor cells.
Differentiation, 72(5), 209-223.
14. El-Badri, N. S., Hakki, A., Ferrari, A., Shamekh, R., & Good, R. A. (2008). Autoimmune disease: is
it a disorder of the microenvironment? Immunol Res, 41(1), 79-86.
15. Giuliani, M., Fleury, M., Vernochet, A., Ketroussi, F., Clay, D., Azzarone, B., et al. (2011). Long-
lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation. PLoS
One, 6(5), e19988.
16. Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W., & Dazzi, F. (2005). Bone marrow mesenchymal stem
cells induce division arrest anergy of activated T cells. Blood, 105(7), 2821-2827.
17. Hahn, B.H. and Singh, R.R. (2007). Animal models of SLE. In D. Wallace and B. Hahn (Eds.),
Dubois Lupus Erythematosus (pp. 299-355). 7th ed. Philadelphia: Lippincott Williams and Wilkins.
18. Hattori, K., Heissig, B., & Rafii, S. (2003). The regulation of hematopoietic stem cell and
progenitor mobilization by chemokine SDF-1. Leuk Lymphoma, 44(4), 575-582.
19. Jaiswal, R. K., Jaiswal, N., Bruder, S. P., Mbalaviele, G., Marshak, D. R., & Pittenger, M. F. (2000).
Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is
regulated by mitogen-activated protein kinase. J Biol Chem, 275(13), 9645-9652.
20. Kyriakou, C., Rabin, N., Pizzey, A., Nathwani, A., & Yong, K. (2008). Factors that influence short-
term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
Haematologica, 93(10), 1457-1465.
21. Lane, N. E. (2006). Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus.
Nat Clin Pract Rheumatol, 2(10), 562-569.
22. Li, L., Xia, Y., Wang, Z., Cao, X., Da, Z., Guo, G., et al. (2011). Suppression of the PI3K-Akt
 pathway is involved in the decreased adhesion and migration of bone marrow-derived mesenchymal
stem cells from non-obese diabetic mice. Cell Biol Int, 35(9), 961-966.
23. Li, Z. H., Liao, W., Cui, X. L., Zhao, Q., Liu, M., Chen, Y. H., et al. (2011). Intravenous
transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the
necrotic femoral head. Int J Med Sci, 8(1), 74-83.
24. Liang, Z., Brooks, J., Willard, M., Liang, K., Yoon, Y., Kang, S., et al. (2007). CXCR4/CXCL12
axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys
Res Commun, 359(3), 716-722.
25. Lin, G. L., & Hankenson, K. D. (2011). Integration of BMP, Wnt, and notch signaling pathways in
osteoblast differentiation. J Cell Biochem, 112(12), 3491-3501.
26. Liu, X., Duan, B., Cheng, Z., Jia, X., Mao, L., Fu, H., et al. (2011). SDF-1/CXCR4 axis modulates
bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell, 2(10),
845-854.
27. Macdonald, G. I., Augello, A., & De Bari, C. (2011). Role of mesenchymal stem cells in
reestablishing immunologic tolerance in autoimmune rheumatic diseases. Arthritis Rheum, 63(9), 2547-
2557.
28. Marone, R., Cmiljanovic, V., Giese, B., & Wymann, M. P. (2008). Targeting phosphoinositide 3-
kinase: moving towards therapy. Biochim Biophys Acta, 1784(1), 159-185.
29. Mendez-Ferrer, S., Michurina, T. V., Ferraro, F., Mazloom, A. R., Macarthur, B. D., Lira, S. A., et al.
(2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature,
466(7308), 829-834.
30. Nie, Y., Lau, C., Lie, A., Chan, G., & Mok, M. (2010). Defective phenotype of mesenchymal stem
cells in patients with systemic lupus erythematosus. Lupus, 19(7), 850-859.
31. Rasmusson, I., Ringden, O., Sundberg, B., & Le Blanc, K. (2005). Mesenchymal stem cells
inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res,
305(1), 33-41.
32. Roland, J., Murphy, B. J., Ahr, B., Robert-Hebmann, V., Delauzun, V., Nye, K. E., et al. (2003). Role of
the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood, 101(2), 399-406.
33. Rombouts, W. J., & Ploemacher, R. E. (2003). Primary murine MSC show highly efficient homing to
the bone marrow but lose homing ability following culture. Leukemia, 17(1), 160-170.
34. Reddy, P. S., Legault, H. M., Sypek, J. P., Collins, M. J., Goad, E., Goldman, S. J., et al. (2008).
Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human
lupus nephritis. Arthritis Res Ther, 10(6), R127.
35. Ryu, C. H., Park, S. A., Kim, S. M., Lim, J. Y., Jeong, C. H., Jun, J. A., et al. (2010). Migration of
human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-
1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem Biophys Res Commun,
398(1), 105-110.
36. Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., et al. (2006).
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone
destruction. J Exp Med, 203(12), 2673-2682.
37. Schenk, S., Mal, N., Finan, A., Zhang, M., Kiedrowski, M., Popovic, Z., et al. (2007). Monocyte
chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells, 25(1), 245-
251.
38. Shi, M., Li, J., Liao, L., Chen, B., Li, B., Chen, L., et al. (2007). Regulation of CXCR4 expression in
human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice.
Haematologica, 92(7), 897-904.
39. Singer, N. G., & Caplan, A. I. (2011). Mesenchymal stem cells: mechanisms of inflammation. Annu
Rev Pathol, 6, 457-478.
40. Singh, R. R. (2005). SLE: translating lessons from model systems to human disease. Trends
Immunol, 26(11), 572-579.
41. Stylianou, K., Petrakis, I., Mavroeidi, V., Stratakis, S., Vardaki, E., Perakis, K., et al. (2011).
The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin.
Nephrol Dial Transplant, 26(2), 498-508.
42. Sun, L. Y., Zhang, H. Y., Feng, X. B., Hou, Y. Y., Lu, L. W., & Fan, L. M. (2007). Abnormality of
bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus,
16(2), 121-128.
43. Sun, Y., Zhang, F. S., & Zhang, Z. Y. (2007). [Immunoregulatory effect of bone marrow mesenchymal
stem cells on regulatory T cells in patients with systemic lupus erythematosis]. Zhonghua Nei Ke Za
Zhi, 46(12), 1018-1021.
44. Sun, L., et al. Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in
Systemic Lupus Erythematosus Mice and Humans." Stem Cells 27 6 (2009): 1421-32. Print.
45. Uccelli, A., Moretta, L., & Pistoia, V. (2006). Immunoregulatory function of mesenchymal stem cells.
Eur J Immunol, 36(10), 2566-2573.
46. Vacanti, V., Kong, E., Suzuki, G., Sato, K., Canty, J. M., & Lee, T. (2005). Phenotypic changes of
adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol,
205(2), 194-201.
47. Van Linthout, S., Stamm, C., Schultheiss, H. P., & Tschope, C. (2011). Mesenchymal stem cells
and inflammatory cardiomyopathy: cardiac homing and beyond. Cardiol Res Pract, 2011, 757154.
48. Wang, D., Shen, W., Zhang, F., Chen, M., Chen, H., & Cao, K. (2010). Connexin43 promotes
survival of mesenchymal stem cells in ischaemic heart. Cell Biol Int, 34(4), 415-423.
49. Westerweel, P. E., Luijten, R. K., Hoefer, I. E., Koomans, H. A., Derksen, R. H., & Verhaar, M. C.
(2007). Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus
erythematosus. Ann Rheum Dis, 66(7), 865-870.
50. Yu, W., Chen, Z., Zhang, J., Zhang, L., Ke, H., Huang, L., et al. (2008). Critical role of
phosphoinositide 3- kinase cascade in adipogenesis of human mesenchymal stem cells. Mol Cell
Biochem, 310(1-2), 11-18.
51. Zhang, H. H., Huang, J., Duvel, K., Boback, B., Wu, S., Squillace, R. M., et al. (2009). Insulin
stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One, 4(7), e6189.
52. Rasmusson, I., Le Blanc, K., Sundberg, B., & Ringden, O. (2007). Mesenchymal stem cells stimulate
antibody secretion in human B cells. Scand J Immunol, 65(4), 336-343.
53. Li, Z. H., Liao, W., Cui, X. L., Zhao, Q., Liu, M., Chen, Y. H., et al. (2011). Intravenous transplantation of
allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral
head. Int J Med Sci, 8(1), 74-83.